Harmony Biosciences Holdings Inc share price logo

Harmony Biosciences Holdings Inc Share Price

NASDAQ: HRMY

Small Cap

$27.07

-0.53

(-1.92%)

as on

Harmony Biosciences Holdings Inc Stock Performance

as on March 25, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $26.75
    $27.36
    downward going graph

    1.18%

    Downside

    1.07%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $25.52
    $40.87
    downward going graph

    5.73%

    Downside

    50.98%

    Upside

    downward going graph

Harmony Biosciences Holdings Inc share price movements today

Previous Close
$27.60
Open
$27.36
Volume
1.1M
Day's Low - High
$26.75 - $27.36
52 Week Low - High
$25.52 - $40.87

Harmony Biosciences Holdings Inc Historical Returns

1 Month Return
-2.09 %
3 Month Return
-28.29 %
1 Year Return
-16.34 %
3 Year Return
-33.8 %
5 Year Return
-7.23 %

Harmony Biosciences Holdings Inc Stock Fundamentals & Key Indicators

Check Harmony Biosciences Holdings Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.6B

EPS (TTM)

4.7941

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.55%

PE Ratio (TTM)

10.23

Industry PE ratio

7.867522123893806

PEG Ratio

0

EBITDA

233.8M

Revenue (TTM)

868.5M

Profit Margin

18.27%

Return On Equity TTM

20.75%

Harmony Biosciences Holdings Inc Stock Valuation

Track how Harmony Biosciences Holdings Inc P/E has moved over time to understand its valuation trends.

Harmony Biosciences Holdings Inc in the last 5 years

  • Overview

  • Trends

Lowest (-14.38x)

March 31, 2021

Industry (7.87x)

March 25, 2026

Today (10.23x)

March 25, 2026

Highest (48.02x)

December 31, 2021

LowHigh

Today’s Price to Earnings Ratio: 10.23x

Harmony Biosciences Holdings Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Harmony Biosciences Holdings Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Harmony Biosciences Holdings Inc image
Harmony Biosciences Holdings Inc
BUY$1.6B-7.23%10.2318.27%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$41.4B126.75%133.418.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$115.3B112.49%29.6832.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$31.6BNA1115.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$77.5B58.91%17.6731.41%

Stock Returns calculator for Harmony Biosciences Holdings Inc Stock including INR - Dollar returns

The Harmony Biosciences Holdings Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Harmony Biosciences Holdings Inc investment value today

Current value as on today

₹91,596

Returns

₹8,404

(-8.4%)

Returns from Harmony Biosciences Holdings Inc Stock

₹17,945 (-17.94%)

Dollar Returns*

₹9,541 (+9.54%)

Analyst Recommendation on Harmony Biosciences Holdings Inc Stock

Based on 14 analysts

BUY

78.57%

Buy

7.14%

Hold

14.29%

Sell

Based on 14 analysts, 78.57% of analysts recommend a 'BUY' rating for Harmony Biosciences Holdings Inc. Average target price of $42

Harmony Biosciences Holdings Inc Share Price Target

Get share price movements and forecasts by analysts on Harmony Biosciences Holdings Inc.

What analysts predicted

35.55%UPSIDE

Target Price

$42

Current Price

$27.07

Analyzed by

14 Analysts

Target

$42.00

Harmony Biosciences Holdings Inc target price $42, a slight upside of 35.55% compared to current price of $27.07. According to 14 analysts rating.

Harmony Biosciences Holdings Inc Stock’s Investor Sentiment and Interest

Search interest for Harmony Biosciences Holdings Inc Stock has decreased by -31% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-31% versus previous 30 day period

Harmony Biosciences Holdings Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
160
168
154
172
186
201
184
200
239
243
Gross Profit
127
125
127
140
143
146
152
162
179
175
Operating Income
64
40
52
21
61
55
56
48
65
38
EBITDA
64
61
62
32
72
66
66
59
73
51
Interest Expense
7
4
4
4
4
4
3
3
3
3
Depreciation
6
6
6
6
5
5
5
5
5
7
Income Before Tax
51
39
51
21
62
56
57
49
67
40
Income Tax Expense
13
13
13
10
16
6
11
9
16
18
Net Income
38
26
38
11
46
49
45
39
50
22
Net Profit Margin
24.00%
15.80%
24.79%
6.71%
24.78%
24.58%
24.66%
19.84%
21.24%
9.22%

Harmony Biosciences Holdings Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
5
159
305
437
582
714
868
Gross Profit
0
4
132
249
354
460
557
670
Operating Income
-41
-145
16
87
120
192
190
208
EBITDA
-41
-142
1
80
146
221
233
255
Interest Expense
-
6
28
24
18
23
17
14
Depreciation
0
3
10
18
23
24
24
25
Income Before Tax
-39
-151
-36
37
104
173
191
215
Income Tax Expense
1
6
14
2
-76
44
46
56
Net Income
-39
-151
-36
34
181
128
145
158
Net Profit Margin
0.00%
-2535.06%
-23.13%
11.33%
41.44%
22.14%
20.36%
18.27%

Harmony Biosciences Holdings Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
26
38
11
46
49
45
39
50
22
Operating Cash Flow
76
31
42
70
75
33
79
108
126
Investing Cash Flow
-36
-6
-54
0
-7
2
-19
-4
-17
Financing Cash Flow
-53
-3
-3
-1
-2
0
-2
-2
-3
Change in Cash
-12
21
-15
70
65
35
57
100
105

Harmony Biosciences Holdings Inc Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-151
-36
34
181
128
145
158
Operating Cash Flow
-75
-2
98
144
219
219
348
Investing Cash Flow
-127
-2
-100
-141
-46
-67
-39
Financing Cash Flow
143
209
7
6
-105
-10
-9
Change in Cash
-58
204
5
9
67
141
299

Global Institutional Holdings in Harmony Biosciences Holdings Inc

Funds
Holdings
Vanguard Group Inc
8.32%
SG Americas Securities, LLC
1.66%
Massachusetts Financial Services Company
0.94%
Armistice Capital, LLC
0.86%
venBio Partners LLC
0.85%
See all

Harmony Biosciences Holdings Inc News & Key Events

  • img

    Today's Timeline - 19 February

    Thu, 06:04 PM

    -

    Harmony Biosciences' 2026 EPS estimates rise from $3.72 to $4.00; shares down 3.7% over six months.

Insights on Harmony Biosciences Holdings Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 184.73M → 243.77M (in $), with an average increase of 8.6% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 16.1% return, outperforming this stock by 32.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Harmony Biosciences Holdings Inc has experienced a drawdown of -33.8%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 23.6%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, HRMY stock has moved down by -28.3%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 50.86M → 22.48M (in $), with an average decrease of 55.8% per quarter

About Harmony Biosciences Holdings Inc

patients are at the beginning, middle, and heart of all we do. harmony biosciences, llc, is a privately-owned biopharmaceutical company. the company was established in october 2017 with a vision to provide novel treatment options for people living with rare and orphan diseases with an emphasis on central nervous system disorders, starting with a focus on helping patients who live with narcolepsy. harmony biosciences is committed to advancing the understanding of narcolepsy and providing information and resources to individuals who live with, and healthcare professionals who treat, patients with narcolepsy.
OrganisationHarmony Biosciences Holdings Inc
Headquarters630 West Germantown Pike, Plymouth Meeting, PA, United States, 19462
IndustryHealth Technology
CEODr. Jeffrey M. Dayno M.D.
E-voting on sharesClick here to vote

Key Management of Harmony Biosciences Holdings Inc

Name

Title

Dr. Kumar Budur M.D., M.S.

Executive VP and Chief Medical & Scientific Officer

Mr. Andrew Serafin J.D., M.B.A.

Executive VP & Chief Strategy Officer

Brennan Doyle

VP & Head of Investor Relations

Ms. Tricia Glover

Chief Compliance Officer

Ms. Audrey Murphy SPHR

Chief Human Resources Officer

Mr. Adam Zaeske

Executive VP & Chief Commercial Officer

Mr. Jeffrey S. Aronin

Founder & Non-Executive Chairman

Mr. Christian Ulrich J.D.

Executive VP, General Counsel & Corporate Secretary

Ms. Cate McCanless

Senior VP & Chief Corporate Affairs Officer

Dr. Jeffrey M. Dayno M.D.

President, CEO & Director

FAQs

What is Harmony Biosciences Holdings Inc share price today?

Harmony Biosciences Holdings Inc share price today is $27.07 as on at the close of the market. Harmony Biosciences Holdings Inc share today touched a day high of $27.36 and a low of $26.75.

What is the 52 week high and 52 week low for Harmony Biosciences Holdings Inc share?

Harmony Biosciences Holdings Inc share touched a 52 week high of $40.87 on and a 52 week low of $25.52 on . Harmony Biosciences Holdings Inc stock price today i.e. is closed at $27.07,which is 33.77% down from its 52 week high and 6.07% up from its 52 week low.

What is Harmony Biosciences Holdings Inc's market capitalisation today?

Harmony Biosciences Holdings Inc market capitalisation is $0.00T as on .

How to invest in Harmony Biosciences Holdings Inc Stock (HRMY) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Harmony Biosciences Holdings Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Harmony Biosciences Holdings Inc Shares that will get you 0.0554 shares as per Harmony Biosciences Holdings Inc share price of $27.07 per share as on March 25, 2026 at 1:29 am IST.

What is the minimum amount required to buy Harmony Biosciences Holdings Inc Stock (HRMY) from India?

Indian investors can start investing in Harmony Biosciences Holdings Inc (HRMY) shares with as little as ₹93.734 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹937.34 in Harmony Biosciences Holdings Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Harmony Biosciences Holdings Inc share’s latest price of $27.07 as on March 25, 2026 at 1:29 am IST, you will get 0.3694 shares of Harmony Biosciences Holdings Inc. Learn more about fractional shares .

What are the returns that Harmony Biosciences Holdings Inc has given to Indian investors in the last 5 years?

Harmony Biosciences Holdings Inc stock has given -7.23% share price returns and 28.4% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?